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Abstract
Objectives—To determine the incidence
and sources of bacterial arthritis in the
Amsterdam health district and the
maximum percentage of cases that
theoretically would be preventable.
Methods—Patients with bacterial arthri-
tis diagnosed between 1 October 1990 and
1 October 1993 were prospectively
reported to the study centre by all 12 hos-
pitals serving the district. Data were gath-
ered on previous health status, source of
infection, and microorganisms involved.
Results—188 episodes of bacterial arthri-
tis were found in 186 patients. Most of the
38 children were previously healthy. Fifty
per cent of the adults were 65 years or
older.Of the adults 84% had an underlying
disease, in 59% a joint disorder. Joint sur-
gery constituted the largest part of direct
infections (33%) and skin defects were the
most important source of haematogenous
infections (67%). Infection of joints
containing prosthetic or osteosynthetic
material by a known haematogenous
source occurred 15 times (8%). Staphylo-
coccus aureus was the causative organism
in 44% of all positive cultures.
Conclusion—The incidence of bacterial
arthritis was 5.7 per 100 000 inhabitants
per year. Preventive measures directed to
patients with prosthetic joints or osteo-
synthetic material, and a known haema-
togenous source would have prevented at
most 8% of all cases.
(Ann Rheum Dis 1997;56:470–475)
The mortality of bacterial arthritis ranges from
10 to 25%.1–4 Permanent loss of joint function
occurs in 25 to 50% of all surviving patients.1–4
These percentages are higher for patients with
underlying joint disorders, partly because early
diagnosis of bacterial arthritis is often
diYcult.3–5 For the general population the inci-
dence of bacterial arthritis has been estimated
to be two cases per 100 000 inhabitants per
year.6 7 Estimates of the incidence of bacterial
arthritis in patients with rheumatoid arthritis
range between 28 and 38 per 100 000 inhabit-
ants per year,7–9 and in patients with joint pros-
theses between 40 and 68 per 100 000 inhabit-
ants per year.10 11 The increased risk and
generally poorer outcomes among patients
with underlying joint disorders suggest a need
for preventive measures.
Bacterial arthritis is usually haematogenous.5
Haematogenous infections can, theoretically,
be prevented by giving antibiotics before or
during bacteraemia. Guidelines analogous to
those for the prophylaxis of endocarditis have
been proposed for the treatment of patients
with joint prostheses.12–15 In general, these are
that antibiotics should be given before surgery
or other interventions with risk of bacteraemia
and as early as possible in the event of
infections. Physicians and dentists called upon
to put such measures into practice have
objected that there is too little evidence to jus-
tify such a regimen.16 17 Preventive measures
may be indicated only in cases of increased
risk.18
In 1990 we started a large scale study on risk
factors,19 on outcome,4 and on incidence and
sources of bacterial arthritis, to gather evidence
for national guidelines for prophylaxis of
bacterial arthritis. This report describes all
cases of bacterial arthritis detected during
three years in the Amsterdam health district. It
extends on previous reports describing the 37
cases with pre-existent joint diseases attending
a rheumatic disease clinic from the study on
risk factors, and the 154 patients (seen before
April 1993), in whom the outcome was
assessed in a follow up study. Here, we report
the incidence of bacterial arthritis and details
regarding route of infection, joints, microor-
ganisms, and sources to get an impression to
what extent prevention had been possible.
Methods
This study was carried out in the Amsterdam
health district, the Netherlands, which has 1.1
million inhabitants.20
Cases in which the diagnosis of bacterial
arthritis or prosthetic joint infection was made
between 1 October 1990 and 1 October 1993
were included. Criteria for the diagnosis were
derived from those of Newman: positive
culture or direct identification of microorgan-
isms in synovial fluid or tissue, or macroscopic
pus produced by arthrocentesis or a clinical
presentation of synovitis with rapidly
progressive joint destruction on radiographs,
or a strong clinical suspicion without
alternative explanation.21
The detection of cases occurred by several
routes. The orthopaedic surgeons, internists,
rheumatologists, and paediatricians of the dis-
trict’s 12 general hospitals were informed
before the start of the study and agreed to
report all cases of joint infection. The seven
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bacteriological laboratories in the district
reported all positive results of cultures of syno-
vial fluid or tissue. In addition, the diagnosis
registries in the district reported all patients
with a diagnosis of joint infection. After
obtaining oral informed consent from all
patients the medical records were consulted.
One investigator (CJEK) recorded the patient’s
age and current status of health, any
underlying joint disorder, the joints involved,
whether there were prosthetic joints or joints
containing osteosynthesis material, the source
of infection, the causative organism, and the
basis upon which the diagnosis had been made.
Patients with concomitant chronic diseases
likely to impair host defences such as cancer,
acquired immunodeficiency syndrome
(AIDS), diabetes mellitus, chronic obstructive
lung disease, renal insuYciency, and patients
using immunosuppressive or illicit intravenous
drugs, were labelled as immunocompromised
patients.
Two diVerent pathogenetic routes of
infection were recognised: direct and
haematogenous. Bacterial arthritis was consid-
ered as direct in origin in case of suspicious
clinical course (wound drainage, incomplete
pain relief, persistent increase in sedimentation
rate, early radiographic signs of loosening,
without another identified source, for example,
cutaneous infection, urinary tract infection)22
after an invasive joint procedure, or penetrating
trauma, or local spread in the course of osteo-
myelitis, cellulitis, abscesses, tenosynovitis or
septic bursitis. Otherwise it was considered to
be haematogenous. An extra-articular infection
or intervention was considered to be the source
of infection if it had occurred less than three
months before the onset of bacterial arthritis
and the species isolated from the infected joint
was compatible with the hypothetical source.
Although with corticosteroids injected joints
are temporarily more susceptible to haematog-
enous infection,23 we classified infections
secondary to intra-articular injections as
direct.
We considered cultures that grew Staphyloco-
ccus epidermidis or Propionibacterium acnes to be
positive only if a Gram stain showed large
numbers of leucocytes and bacteria or if a sec-
ond culture produced the same result. We
recorded an episode of bacterial arthritis in a
previously aVected patient as a new case if the
preceding episode had been adequately treated
and the patient had remained free of symptoms
for an intervening period of at least three
months. Cases of infectious spondylodiscitis
were not included in this study.
Results
INCIDENCE
One hundred eighty eight cases of bacterial
arthritis were registered during the three year
course of the survey. This yields an incidence
of 5.7 per 100 000 inhabitants per year (95%
confidence intervals: 4.9, 6.5). The cases were
distributed over 186 patients, 97 men (52%)
and 89 women (48%). There were two peaks in
the age specific incidence: children below the
age of 5 made up 6% of the study population,20
but accounted for 14% of the registered cases;
adults above the age of 64 made up 13% of the
study population, but accounted for 39% of
the registered cases.
CLINICAL PROFILES
In 157 cases bacterial arthritis was diagnosed
on the basis of positive cultures or direct iden-
tification of microorganisms in joint fluid or
synovial tissue, in 19 cases on the presence of
pus in the aVected joint, and in eight cases on
the rapidly progressive joint destruction on
radiographs. Three children and one adult
were diagnosed as having bacterial arthritis on
the basis of the typical clinical picture together
with positive cultures of blood and material
from the assumed source of infection.
Table 1 gives the clinical characteristics of
the patients. Of the 38 children 31 had been
previously healthy, while seven had a concomi-
tant disease—in two cases disorders of
neutrophil function.
Of the 150 adults 23 had no underlying dis-
orders. Thirty seven adult patients were subject
to disorders that directly or indirectly compro-
mised their host defences. These were: use of
intravenous drugs in 14 patients (six of them
infected with the human immunodeficiency
virus (HIV)), diabetes mellitus in 11 patients,
renal insuYciency in four (two of them requir-
ing regular dialysis), haematological malig-
nancy in three, AIDS in two, and chronic
osteomyelitis in two. In one each: polymyalgia
rheumatica treated with prednisone, chronic
obstructive pulmonary disease intermittently
treated with prednisone, leprosy, and misuse of
alcohol.
Eighty nine patients (47% of all cases) had
underlying joint disorders. These were
rheumatoid arthritis and osteoarthritis each in
32 patients. Other joint diseases, which
occurred in one patient each, were juvenile
chronic arthritis, psoriatic arthritis, and
ankylosing spondylitis. One patient had a
history of tuberculous coxitis. In the remaining
21 patients joints had been damaged or had
been replaced in the past because of traumatic
damage. The immune system of 25 of these 89
patients was compromised as a result of medi-
cation (18 patients), diabetes mellitus (6
patients), and breast cancer (4 patients).
JOINTS INVOLVED
In total, 214 infected joints were registered
(table 2); knees (48%) and hips (21%) were
most commonly aVected. Among children
ankles were involved in 21%, knees in 32%,
and hips in 34%. Among adults all except one
of the 22 infected hips contained a prosthesis
or osteosynthesis material. Among the adult
patients in whom only native joints were
involved were three patients with prostheses in
un-involved joints. Of the 214 infected joints
58 (27%) contained prosthetic or osteosyn-
thetic material; 25 were haematogenously
infected and 33 by a ‘direct’ cause such as joint
surgery.
There were 18 patients with polyarticular
bacterial arthritis, among them two children.
One of them had been healthy before infection,
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in the other later investigations demonstrated
impaired bacterial killing capacity of the
granulocytes. Among adults the polyarticular
cases were proportionately distributed between
those with underlying joint disorders and those
without. Five of 16 adults with more than one
infected joint had rheumatoid arthritis, in con-
nection with which three were taking
prednisone.
SOURCES OF INFECTION
Table 3 gives the sources of infection according
to patient category. In 126 cases (67%) the
infection was haematogenous, in 62 cases it
was direct. In children the sources of
haematogenous infection were known in 16
(44%). Those that could be determined
included infections of the airways in 12 cases
and infected skin lesions in four. Among adults
it was possible to determine the sources of
infection in 60 cases (67%). Thirty eight of
these were infected skin lesions, 10 of the feet.
Invasive medical interventions distant from
the aVected joints led to bacterial arthritis of a
prosthetic joint in one patient: after cystoscopy
without antibiotic prophylaxis infection
developed around a total hip prosthesis. Bac-
terial arthritis of a native joint caused by an
invasive procedure at a distant site occurred in
six cases. Bacterial arthritis after an urological
intervention developed in a second case: an
osteoarthritic knee became infected after the
placement of a catheter and lavage of the blad-
der while taking antibiotics for urinary tract
infection. In each case the same bacteria were
found in the urine and in the pus from the
infected joint. In five cases bacterial arthritis
was secondary to an intervention involving the
skin. Three of these involved opening and
draining of abscesses: one at the injection site
in a user of illicit drugs, a second patient need-
ing long term haemodialysis had a panaritium,
and a third patient with chronic non-
tuberculous osteomyelitis elsewhere in the
skeleton developed an abscess in the groin.
One patient developed a septic shoulder joint
after infection at the insertion site of an
intravenous infusion needle at the dorsum of
the contralateral hand. In another patient the
insertion of a right sided subclavian catheter
for the administration of cytostatic drugs led to
an episode of bacterial arthritis in one ankle
and in the right acromioclavicular joint.
Table 1 Cases of bacterial arthritis or infected joint prosthesis according to clinical category and infection route
Patient category
Total
(n=188)
Haematogenous
infection of
native joints
(n=101)
Haematogenous
infection of joints with
prosthetic or
osteosynthetic material
(n=25)
Direct
infection of
native joints
(n=29)
Direct infection of
joints with
prosthetic or
osteosynthetic
material (n=33)
Children 38 36 - 2 -
Previously healthy 31 29 2
Concomitant disease* 7 7
Adults, previously healthy 23 16 - 7 -
Adults, immunocompromised† 38 32§ - 6 -
Adults with joint disorders: 63 8 15 13 27
Osteoarthritis 28 5 8 4 11
Rheumatoid arthritis 13 2 5 1 5
Ankylosing spondylitis 1 1
Psoriatic arthritis 1 1
Juvenile chronic arthritis 1 1
History of joint trauma 18 1 2 7 8
History of tuberculous coxitis 1 1
Adults, with joint disorders and
immunocompromised‡ 26 9 10 1 6
Osteoarthritis 4 2 2
Rheumatoid arthritis 19 6 10 3
History of joint trauma 3 1 1 1
* Sickle cell trait in two cases; bronchial asthma with eczema, Duchenne’s muscular dystrophy, history of cardiosurgery, impaired
killing capacity of neutrophils and impaired chemotaxis of neutrophils, each in one case.
† Intravenous drug abuse in 14 (six HIV infected), diabetes mellitus in 11, renal insuYciency in three (two requiring regular
dialysis), hematological malignancy in three, AIDS in two and chronic osteomyelitis in two cases. In one cases each: polymyalgia
rheumatica treated with prednisone, chronic obstructive lung disease intermittently treated with prednisone, leprosy and alcohol
abuse.
‡ Diabetes mellitus in six, breast cancer in four, renal insuYciency in one, and immunosuppressive medication (prednisone,
methotrexate or azathioprine) in 18 cases.
§ Two patients, both intravenous drug misusers, had each two episodes of bacterial arthritis.
Table 2 Infected joints related to route of infection and underlying condition
Total (%)
Haematogenous infection Direct infection
All Children
Adults without
joint disorder
Adults with joint
disorder* All Children
Adults without
joint disorder
Adults with
joint disorder*
Sternoclavicular 4 (2) 4 3 1
Shoulder 9 (5) 5 4 1 4 4
Elbow 17 (9) 13 3 3 7 (1) 4 4 (4)
Wrist 13 (7) 13 2 5 6 (1)
Hand joints 7 (4) 7 1 6
Sacroiliac 2 (1) 2 1 1
Hip 39 (21) 24 13 3 8 (8) 15 1 14 (13)
Knee 91 (48) 68 11 32 25 (14) 23 1 3 19 (12)
Ankle 23 (12) 16 8 6 2 7 2 5 (4)
Foot joints 9 (5) 6 1 5 (1) 3 2
All joints 214 151 38 58 55 (25) 63 2 14 47 (33)
* Numbers in parentheses refer to cases with infections around prosthetic or osteosynthetic material.
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Infections subsequent to direct interventions
in joints occurred in 43 patients (23% of
all patients): after joint surgery in 40,
intra-articular injection with corticosteroids in
two, and multiple periarticular injections with
an anaesthetic in one case. Surgery consisted of
placement of a prosthesis in 20 patients, of
implantation of osteosynthesis material in 11,
and of joint surgery not involving foreign
material in nine patients—included among
these were three arthroscopies of the knee, two
therapeutic and one diagnostic.
Bacterial arthritis caused by trauma to the
joint occurred in 13 patients, among them two
children. Both children and seven adults were
previously healthy. Eight of 13 patients in this
category had bacterial arthritis of a finger or
toe joint.
In four patients invasion of the joint by
pathogens occurred by contiguity from
infectious skin lesions of the overlying skin. In
two other patients the source of infection was
juxta-articular chronic osteomyelitis, one of
them tuberculous.
BACTERIA
Twenty four species of bacteria were identified
in cultures of material from infected joints
(table 4). Irrespective of clinical category
Staphylococcus aureus was the most common,
being found in 44% of all positive cultures. In
72% of these the strain was penicillin resistant.
Streptococci and Gram negative bacilli were
the second and third most common categories
of bacteria, in 21 and 17% respectively.Neisse-
ria gonorrhoea was not found.
The most frequently cultured bacteria in
children were S aureus and H influenzae. S
aureus was cultured exclusively in children
younger than 6 months or older than 5 years.H
influenzae was found in seven patients, six of
them aged between 6 months and 2 years. In all
five patients in whom typing of H influenzae
was performed, the serotype was b. In 12 chil-
dren no microorganisms were identified.
In adults cultured bacteria in native joints
versus joints containing foreign material
diVered in that Staphylococcus epidermidis,
group B streptococcus, group D streptococcus,
and Gram negative bacilli were seen more
often in the latter.
Discussion
The overall incidence of bacterial arthritis
reported here is somewhat higher than was
found in earlier studies.6 7 The diVerence might
be because of the small incidence of
underreporting in our study and the increased
frequency of surgical joint procedures over the
past decade. The cooperation of clinicians and
microbiologists from all general hospitals and
bacteriological laboratories and, afterwards,
from the diagnosis registries in the health
district, minimised the chance of underreport-
ing cases. Any underestimation is probably
because of unreported occurrences of bacterial
arthritis in cases of terminal sepsis and the
departure of cases in which patients received
early treatment. The region in which the survey
took place consisted of two thirds of the habit-
ants of the city of Amsterdam; we have no clues
that the observed incidence rate is influenced
by the relative often use of drugs or by a higher
frequency of AIDS.
Bacterial arthritis occurs most frequently
among children and the elderly. In very young
children the epiphysis and metaphysis are
joined by vascular anastomoses, which may
provide additional paths for the dissemination
of infection.1 24 Among the elderly in addition
to age itself the occurrence of bacterial arthritis
is probably related to concomitant joint and
immunocompromising disorders.25–27 In our
survey, 88% of the patients aged 70 years or
older, but only 56% of the remaining adults,
had an underlying joint disease, diabetes melli-
tus, a malignancy, or was taking immunosup-
pressive medication.
The clinical profiles of patients with
bacterial arthritis are continually changing.5 6 28
In our series 56% of the patients with
infections around a prosthesis were aged 70
years or older, forming a group that does not
occur in earlier surveys. The percentages of
patients using immunosuppressive medication
or infected with HIV were also higher than
those found in previous studies.2 6–11 29–36 To a
certain extent these changes may reflect the
Table 3 Sources of infection
Total
Children Adults
All
children
Previously
healthy
Concomitant
disease
All
adults
Previously
healthy Immunocompromised
Joint
disorder†
Joint disorder and
immunocompromised†
Haematogenous 126 36 29 7 90 16 32 23 (15) 19 (10)
Skin 42 4 4 38 5 15 10 (7) 8 (3)
Upper airways 4 12 10 2 2 1
Lower airways 16 6 2 4 1 (1)
Urinary tract 7 7 1 1 5 (3)
Non-sterile intervention distant from
infected joint:
Skin 5 5 5
Urological 2 2 2 (1)
Unknown 50 20 15 5 30 8 7 9 (6) 6 (4)
Direct 62 2 2 60 7 6 40 (27) 7 (6)
Joint surgery* 40 40 33 (25) 7 (6)
Intra-articular injection 3 3 3 (1)
Trauma 13 2 2 11 7 1 3 (1)
Infection of overlying skin 4 4 4
Chronic osteomyelitis 2 2 1 1
* Included are two therapeutic and one diagnostic arthroscopy.
† Numbers in parentheses refer to cases with infections around prosthetic or osteosynthetic material.
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method by which we collected our data.The data
in most of the series described in published
reports came from the orthopaedic or rheuma-
tological departments of single hospitals rather
than from whole districts.2 6–11 29–36
A fifth of all patients were aged 15 years or
younger; H influenzae was cultured compara-
tively often in this group. It can be expected
that H influenzae type b as a causative organism
will decrease in the coming years because of
the introduction of an additional national pro-
gramme of vaccination in children born after
31 December 1992.
Rheumatoid arthritis patients treated with
immunosuppressive drugs constituted the
majority of the clinical category of 25 adults
with an underlying joint disease as well as an
immunocompromising condition. Patients
with rheumatoid arthritis frequently develop
infections at the site of skin defects particularly
on the feet.36 The integrity of the skin is threat-
ened by deformations, nodules, and atrophy
resulting frommedication.37 In 14 (64%) of the
22 rheumatoid arthritis patients with
haematogenous bacterial arthritis infected skin
lesions were the sources of infection. These
were on the feet in eight patients.
There were only seven cases of bacterial
arthritis secondary to medical interventions
other than in the joints. A call for reporting
similar cases advertised in a national medical
journal and in the newsletters of the orthopae-
dic and rheumatological societies brought just
one more to light: an infection with Proteus
mirabilis around a hip prosthesis secondary to a
dilatation of the urethra without antibiotic
prophylaxis. Recently revised national guide-
lines for patients with hip prostheses call for
prevention and early treatment of infections
elsewhere in the body and for the prophylactic
use of amoxicillin-clavulanate in all patients
with prosthetic joints submitted to invasive
interventions with risk of bacteraemia.13 These
guidelines are analogous with those in
endocarditis prophylaxis. Experience in the lat-
ter however,38 39 and the use of antibiotic
prophylaxis as reported by patients with joint
diseases19 show low compliance.
The absence of gonococcal arthritis in our
study is remarkable. Despite the additional
cooperation of dermatovenereologists in
venereal disease outpatient clinics and the
occurrence of patients with bacterial arthritis
in a subpopulation where gonorrhoea is more
frequently seen (six of the 14 users of
intravenous drugs were prostitutes), we found
no case of gonococcal arthritis. There has been
a steep decrease of annual new cases of gonor-
rhoea,40 probably related to safe sex
promotional campaigns against AIDS. Another
possible reason is that the survey lasted for too
short a period to detect a rare disease; before
and after the duration of the study a few
patients with gonococcal arthritis were seen.
In theory, the potentially preventable cases
of bacterial arthritis are those in which there is
an impaired immune system at the local or the
systemic level and (the threat of) bacteraemia.
Immunocompromised patients without joint
disorders form a heterogeneous group,
not amenable to prophylactic measures
directed at preventing bacterial arthritis other
than general principles of good clinical care
including rapid treatment of infections and
alertness in case of bacteraemia. As strict
adherence to antiseptic procedures during
Table 4 Cultured microorganisms in relation to underlying condition
Microorganism Total*
Children Adults
All
Previously
healthy
Concomitant
disease All
Previously
healthy Immunocompromised
Joint
disorder
Joint disorder and
immunocompromised
Staphylococcus 97 (48) 9 (24) 6 3 88 (53) 9 (39) 28 (64) 38 (52) 13 (50)
S aureus 23 2 2 21 4 9 5 3
S aureus, penicillin resistant 60 7 4 3 53 5 18 24 6
S epidemidis 11 11 1 6 4
Species 3 3 3
Streptococcus 37 (18) 8 (21) 6 2 9 (17) 7 (30) 5 (11) 15 (21) 2 (8)
Group A 10 4 4 6 3 2 1
Group B 7 7 3 4
Group D 2 2 2
Group G 7 7 1 5 1
S pneumoniae 7 4 2 2 3 1 1 1
S mitis 1 1 1
Species 3 3 2 1
Gram negative bacilli 30 (15) 8 (21) 7 1 22 (13) 1 (4) 5 (11) 10 (14) 6 (23)
Escherichia coli 9 9 4 5
Proteus mirabilis 2 2 1 1
Klebsiella species 1 1 1
Enterobacter cloacae 2 2 1 1
Citrobacter freundii 1 1 1
Pseudomonas aeruginosa 5 5 1 4
Haemophilus influenzae 8 7 6 1 1 1
Haemophilus parainfluenzae 1 1 1
Pasteurella multocida 1 1 1
Other bacteria 16 (8) 1 (3) 1 15 (9) 3 (13) 5 (11) 6 (8) 1 (4)
Bacteroides species 3 3 1 2
Peptostreptococcus prevotii 1 1 1
Corynebacterium species 1 1 1
Neisseria meningitidis 2 1 1 1 1
Propionibacterium acnes 3 3 2 1
Borrelia burgdorferi 1 1 1
Mycobacterium tuberculosis 5 5 1 2 2
Unknown 24 (12) 12 (32) 1 1 12 (7) 3 (13) 1 (2) 4 (5) 4 (15)
* Numbers in parentheses are percentages.
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invasive interventions of joints is common
practice, not much additional benefit is to be
expected in this category. More, however little
it may be, is to be expected from the prevention
of haematogenous bacterial arthritis among
patients with underlying joint diseases. In this
study that category was represented by 42
patients, 25 of whom had infections around
joint prostheses or osteosynthetic material.
Provided the potential source of the infection
would have been detected in time, prophylaxis
according to the regimen recommended by
current consensus would have prevented
haematogenous bacterial arthritis in those 25
patients (17% of all adult patients). In 10
(40%) of these patients however, the source of
infection could not be determined. Most
potentially preventable cases are patients with
infections around joint prostheses and a known
haematogenous source; they form 8% (15 of
188) of all cases with joint infection. Whether
these cases can really be prevented and how
much eVort has to be done to get there,
remains to be seen.
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